Foghorn Therapeutics Inc (FHTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 92,795 | 75,161 | 0 | 0 | N/A |
| Marketable Securities | 92,975 | N/A | 0 | 0 | N/A |
| TOTAL | $190,687 | $77,764 | $0 | $0 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 19,528 | 16,848 | N/A | N/A | N/A |
| Other Non-Current Assets | 45,379 | 47,816 | 0 | 0 | 0 |
| TOTAL | $64,907 | $64,664 | $N/A | $N/A | $N/A |
| Total Assets | $255,594 | $142,428 | $0 | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,680 | 3,554 | 0 | 0 | 0 |
| Accrued Expenses | 9,161 | 9,970 | 0 | 0 | N/A |
| TOTAL | $18,846 | $21,301 | $0 | $0 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 19,654 | 8,801 | 0 | 0 | N/A |
| Deferred Revenues | 2,024 | 1,696 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 58,361 | 56,119 | 0 | 0 | 0 |
| TOTAL | $90,561 | $78,045 | $N/A | $N/A | $N/A |
| Total Liabilities | $109,407 | $99,346 | $0 | $0 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 36,817 | 35,814 | N/A | N/A | N/A |
| Common Shares | 4 | 1 | 0 | 0 | N/A |
| Retained earnings | -162,936 | -142,178 | 0 | 0 | N/A |
| Other shareholders' equity | -7 | 176,405 | 0 | 0 | 0 |
| TOTAL | $146,187 | $43,082 | $0 | $0 | $N/A |
| Total Liabilities And Equity | $255,594 | $142,428 | $0 | $0 | $0 |